GlassScriptPhysician profile
David Wong
NPI 1245771112
$3,028.02
in general payments reported to CMS, 2019-2025
12 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.20 · 2020: $37.08 · 2021: $108 · 2022: $578 · 2023: $577 · 2024: $710 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,198 · Entertainment: $95.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.42 |
| Entertainment | $95.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $837.95 | 2022-2024 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Lumenis Be INC | $610.63 | 2025 | Optilight |
| Bausch & Lomb Americas INC. | $377.70 | 2023-2024 | Infuse, Infuse Multifocal |
| Alcon Vision LLC | $262.49 | 2022-2024 | Precision 1 |
| Oyster Point Pharma, INC. | $176.38 | 2022-2023 | Tyrvaya |
| Regeneron Pharmaceuticals, INC. | $143.20 | 2025 | Eylea |
| Lkc Technologies, INC. | $127.60 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $124.99 | 2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $123.52 | 2020-2024 | |
| Abbvie INC. | $96.94 | 2022 | |
| Optos, INC. | $95.04 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $51.58 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.